Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00944216 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
A Phase 4 study, sponsored by Wright State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT00944216 is a Phase 4 study that was terminated before completion, run by Wright State University. The registered enrollment target is 1 participants.
The verdict
NCT00944216, a Phase 4 study, was terminated before completion, sponsored by Wright State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Keratosis pilaris (KP) is a benign skin condition that often is very frustrating for the patients and treating physicians. The investigators are interested to see if the study product is effective in treating moderate to severe KP.
Interventions
- DRUG Salkera Emollient Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00944216
The ClinicalTrials.gov registry entry for NCT00944216 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Salkera Emollient Foam is the first listed.
NCT00944216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00944216 about?
NCT00944216 is a clinical study titled "Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study". Keratosis pilaris (KP) is a benign skin condition that often is very frustrating for the patients and treating physicians. The investigators are interested to see if the study product is effective in treating moderate to severe KP.
What is the current status of trial NCT00944216?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2009-06. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00944216?
The interventions under investigation include: Salkera Emollient Foam (DRUG).
Who is sponsoring clinical trial NCT00944216?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.